United States · Series A startup

Who invested in Lysosomal Therapeutics

2 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$25Mraised across 2 rounds since 2014, from 2 sources

$4.8MSeed$20MSeries A
Latest round
Series A, $20MFeb 2015
Step-upi
4.2×
Investors
8
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2015
$4.8MSeed$20MSeries A
First round
Seed, $4.8M
May 2014
Biggest round
$20M
Series A · Feb 2015
Between rounds
9 months
from the last two

The rounds

  1. Feb 2015
    Series A$20M1 new6 returning

    From a historical funding recordSEC filing: $10M sold, first sale Jan 2015

  2. May 2014
    Seed$4.8M7 new

    From a historical funding recordSEC filing: $4.8M sold, first sale Apr 2014

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Atlas VentureVC firm2rounds
Roche Venture FundCorporate VC2rounds
Lilly VenturesGrowth equity2rounds
Sanofi-Genzyme BioVenturesCorporate VC2rounds
SanofiInvestment firm1round
Orion Healthcare Equity Partnersno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Lysosomal Therapeutics

Who invested in Lysosomal Therapeutics?

Lysosomal Therapeutics's investors include Atlas Venture, Hatteras Venture Partners, Roche Venture Fund, Partners HealthCare Innovation and Lilly Ventures, and 3 more on record.

How much has Lysosomal Therapeutics raised?

Lysosomal Therapeutics has raised $25M across 2 rounds since 2014.

When did Lysosomal Therapeutics last raise?

Lysosomal Therapeutics's most recent round was a Series A of $20M in Feb 2015.

What was Lysosomal Therapeutics's biggest round?

Its most recent round, $20M in Feb 2015, is also its largest on record.

Who backed Lysosomal Therapeutics first?

Lysosomal Therapeutics's first round on record, in May 2014, was backed by Atlas Venture, Hatteras Venture Partners and Roche Venture Fund and 4 others.

What stage is Lysosomal Therapeutics at?

Lysosomal Therapeutics's latest named round is a Series A, in Feb 2015.

Where is Lysosomal Therapeutics based?

Lysosomal Therapeutics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.